Randomized Clinical Trial in Parkinson's Disease Patients Using Pluripotent Adipose Stem Cells (PASCs)

NCT06141317 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

BIOLOGICAL: PASC transplantation (25 million PASCs/patient)
BIOLOGICAL: Control

Sponsor

ClusterXStem-Costa Rica

Collaborators

[object Object]
[object Object]